Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | 0.00% | +0.61% | -44.03% |
Apr. 11 | BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target | MT |
Apr. 02 | HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating | MT |
Business Summary
Number of employees: 107
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 34 | 15-12-31 | |
Steven Kelly
CEO | Chief Executive Officer | 59 | 18-01-31 |
Richard Morris
DFI | Director of Finance/CFO | 51 | 21-05-31 |
Daniel Cushing
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Tom Wilton
PRN | Corporate Officer/Principal | - | 19-08-31 |
Terry Shields
HRO | Human Resources Officer | - | 23-06-13 |
Eric Siegel
LAW | General Counsel | 60 | 23-06-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Kelly
CEO | Chief Executive Officer | 59 | 18-01-31 |
Sanford Zweifach
CHM | Chairman | 68 | 21-10-31 |
Director/Board Member | 66 | 22-01-31 | |
Regina Hodits
BRD | Director/Board Member | 54 | 18-05-31 |
Briggs Morrison
BRD | Director/Board Member | 65 | 20-06-30 |
Michael Torok
BRD | Director/Board Member | 45 | 23-03-06 |
John Hohneker
BRD | Director/Board Member | 64 | Mar. 31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,542,534 | 27,945,479 ( 67.27 %) | 0 | 67.27 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.03% | 68.13M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- CARM Stock
- Company Carisma Therapeutics, Inc.